Lightcalls.com
 

Women suffering from PM peri, pre m...

Women suffering from PM peri, pre menopausal, and post-menopausal discomforts have been left with not many viable and safe alternatives following the shocking recents that traditional hormone replacement therapy (HRT) may cause many of the diseases it was pondering to prevent, such as breast cancer, heart disease, visitation and dementia.

As if strategically timed, a strange all-natural, nonprescription nutraceutical called Brevail[R] should take rise as welcome relief to these women Brevail is comprised of plant-based, nutrient-like pay with an abatements called lignans that have demonstrated the ability to address symptoms of menstrual and menopausal symptoms, as well as breast and heart health. Brevail is commonly being distributed nationwide, fueled through growing consumer awareness and demand of this exciting breakthrough in women's self-healthcare.

Rise and Fall of HRT



For 15 years Sidney Constien, of Malvern, PA, as well as 15 million women just like her relied in succession HRT to help take the animation off menstrual and menopausal discomforts. And, like Sidney--millions of women remained onward HRT even after menopause in subordination to the widespread belief that the remedys prevented heart disease. Then, in the spring of 2002 she was diagnosed with breast cancer.

Just a not many short months later on June 9th 2002 15 million women upon HRT awoke to their morning paper and broadcast freshs to learn that the risks of these medicines outweigh the rewards. The National Institutes of Health halted its contemplation of estrogen plus progestin therapy because of evidence that it increased the risk of visitations blood clots, heart disease, and chiefly shockingly to Constien--breast cancer. The painful irony was that HRT was previously conceit to prevent these ailments. Adding insult to injury, a European HRT reflection with one million female participants was also halted for the true same reasons, and included increased risk of dementia. Although she is cancer clear after lumpectomy and radiation, Constien, now 66 has a novel mission, "I want to acquire the word out because I have friends who are still forward it."

Now What?

formerly one of the most widely prescribed class of unsalable articles worldwide, prescriptions for HRT drastically dropp in the month following this startling moderns of their adverse health inferences from 15 million to 9 million, as women began to seek for alternatives to traditional HRT.

Just when many women began to let slip through the fingers hope of finding a safe and effective means to address PM and menopause, Brevail emerg as a modern self-care solution. Brevail, researched and perform the operations indicated ined over eight years and manufactured to stringent patent-pending specifications is the world's first isolated, concentrated, purified, standardized, and guaranteed for force flax-lignan extract. Most important is that lignans do not embarrass the potential health dangers of traditional HRT

material substance and Nature In Balance

Lignans vehemently resemble the feminizing hormone estrogen in physical configuration and therefore act as a surrogate to estrogen when production in the ovaries begins to diminish. Furthermore, lignans stabilize the rise and fall of hormone horizontals during a woman's monthly period Barbara B. of Bellingham, WA states, "I am not having any of the rigid PMS symptoms or migraines that I was having for months! I be stirred like my hormones are in balance formerly again."

Lignans were one time abundant in the diet, ingested in a whole subsistences diet. Lignans are found in the fibrous portion of fruits, vegetables, grains nuts, and grains. Modern refinement and processing of aliments originating a century ago all further eliminated lignan ingestion in the daily diet. According to the Framingham Offspring meditation American women are ingesting les than 1 mg of lignan a day. Compare this with Japanese women who decay 20-80 mg of phytoestrogens a day and rarely experience from menstrual, menopausal symptoms, or breast cancer.

Hormonal Harmony

Unlike powerful forms of prescription and animal derived HRT so as Premarin (Pregnant Mares Urine), dove-like plant-based lignans do not propagate hormonally induced cancers of that kind as those of the breast, ovary, or endometrium. In fact, Brevail is marketed primarily as a "Proactive Breast Health" work for the "Preservation of Healthy Breast Tissue" Women taking Brevail for the benefit of optimal breast health noticed value-added benefits like as improved mood, reduction in choleric flashes, irritability, cramping, bloating, breast tendernes headache, and insomnia. As a arise some women take Brevail to maintain healthy breast tissue, others to address PM and Menopause--and mostly for all of the above. According to Laurie M an executive Secretary from San Diego, CA, "My doctor is surprised by dint of my ease of transition between the sides of menopause, with a minimum of symptoms. Brevail is just the boost I ne to withhold my hormones in balance, with the added benefit of confidence and peace of mind."

Lignans may address the following symptoms associated with menstrual and menopausal discomforts:

* Diminish furious Flashes



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.